Guided Therapeutics, Inc. (OTCMKTS:GTHP) Short Interest Down 96.7% in November

Guided Therapeutics, Inc. (OTCMKTS:GTHP) was the recipient of a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 400 shares, a decline of 96.7% from the October 31st total of 12,000 shares. Based on an average trading volume of 9,500 shares, the short-interest ratio is currently 0.0 days.

Guided Therapeutics Stock Performance

Shares of GTHP traded down $0.03 during trading hours on Thursday, reaching $0.16. 4,369 shares of the company traded hands, compared to its average volume of 21,591. The stock’s fifty day moving average is $0.17 and its 200 day moving average is $0.14. The stock has a market cap of $9.76 million, a P/E ratio of -5.33 and a beta of 0.51. Guided Therapeutics has a 1-year low of $0.06 and a 1-year high of $0.25.

Guided Therapeutics Company Profile

Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.